6,7-Dihydro-5H-cyclopenta[b]pyridine-3-carboxylic acid

Catalog No. :
ACVQKN807
CAS No. :
114402-11-8
Molecular Formula :
C9H9NO2
Molecular Weight :
163.18

IUPAC Name:6,7-dihydro-5H-cyclopenta[b]pyridine-3-carboxylic acid

6,7-Dihydro-5H-cyclopenta[b]pyridine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$81.00Login to see priceIn stockInquiry
100mg95%$133.00Login to see priceIn stockIn stock
250mg95%$268.00Login to see priceIn stockIn stock
1g95%$731.00Login to see priceIn stockInquiry
5g95%$3034.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,7-Dihydro-5H-cyclopenta[b]pyridine-3-carboxylic acid
IUPAC Name6,7-dihydro-5H-cyclopenta[b]pyridine-3-carboxylic acid
MDL No.MFCD09035048
Molecular FormulaC9H9NO2
Molecular Weight163.18
SMILESO=C(C1=CN=C2C(CCC2)=C1)O
InChI KeyKDCDSNYNWQNPRU-UHFFFAOYSA-N
Synonym6,7-dihydro-5H-cyclopenta[b]pyridine-3-carboxylic acid;5H-Cyclopenta[b]pyridine-3-carboxylic acid, 6,7-dihydro-;5H,6H,7H-cyclopenta[b]pyridine-3-carboxylic acid
CAS No.114402-11-8
PubChem CID21795913

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVQKN807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCMOU070 route compound structure diagram
    ACCMOU0701318759-82-8 In Stock
  2. Then
  3. ACVQKN807 route product structure diagram
    ACVQKN807114402-11-8 In Stock
Inquiry

2. ACVQKN807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVQKN807 route product structure diagram
    ACVQKN807114402-11-8 In Stock
Inquiry

Comments (0)